XBiotech (XBIT) Net Income (2014 - 2026)

XBiotech has reported Net Income for 13 years, with the latest figure at -$6.7 million in Q2 2026.

• On a quarterly basis, Net Income fell 283.14% year-over-year to -$6.7 million in Q2 2026; TTM through Jun 2026 was -$41.4 million, a 46.94% decrease from a year earlier, with the FY2025 full-year figure at -$45.5 million, down 18.19% from the prior year.
• Net Income was -$6.7 million for Q2 2026 at XBiotech, up from -$26.9 million in the prior quarter.
• The five-year high for Net Income was -$1.8 million in Q2 2025, with the low at -$26.9 million in Q4 2025.
• Average Net Income over 5 years is -$8.7 million, with a median of -$7.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Net Income slumped 288.16% in 2022, then jumped 86.5% in 2025.
• Over 5 years, Net Income stood at -$3.2 million in 2022, then plunged by 46.55% to -$4.7 million in 2023, then tumbled by 123.86% to -$10.5 million in 2024, then tumbled by 155.92% to -$26.9 million in 2025, then jumped by 74.98% to -$6.7 million in 2026.
• The last three Net Income figures came in at -$6.7 million (Q2 2026), -$26.9 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.